Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8DXU | 8DXU | Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex. | |
| 8DXU | P0DTC2 | Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex. | |
| 8DY6 | 8DY6 | Vaccine elicited Antibody MU89+S27Y bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer | |
| 8DYA | A0A8B6RDW3 | Structure of the SARS-CoV-2 spike glycoprotein S2 subunit | |
| 8DZD | A0QY10 | Structure of MS3494 from Mycobacterium smegmatis bound to sucrose | |
| 8DZH | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
| 8DZH | 8DZH | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
| 8DZI | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
| 8DZI | 8DZI | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
| 8E07 | Q9Y251 | Crystal structure of HPSE P6 in complex with triose pentosan inhibitor | |
| 8E08 | Q9Y251 | Crystal structure of HPSE P6 in complex with tetraose pentosan inhibitor | |
| 8E0P | C3SHQ8 | Crystal structure of mouse APCDD1 in fusion with engineered MBP | |
| 8E0P | Q3U128 | Crystal structure of mouse APCDD1 in fusion with engineered MBP | |
| 8E0R | Q3U128 | Crystal structure of mouse APCDD1 in P21 space group | |
| 8E0S | P0AB91 | DAHP (3-deoxy-D-arabinoheptulosonate-7-phosphate) Synthase complexed with DAHP Oxime in unbound:(bound)2:unbound conformations | |
| 8E0V | P0AB91 | DAHP (3-deoxy-D-arabinoheptulosonate-7-phosphate) Synthase complexed with Mn(II), PEP, and Pi in unbound:(bound)2:other Conformations | |
| 8E0W | Q3U128 | Crystal structure of mouse APCDD1 in P1 space group | |
| 8E15 | Q8B9P0 | A computationally stabilized hMPV F protein | |
| 8E15 | Q76VI8 | A computationally stabilized hMPV F protein | |
| 8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8E1G | 8E1G | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8E1P | 8E1P | Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs | |
| 8E1P | Q2N0S6 | Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs | |
| 8E1W | A0A0S2GKZ1 | Neutron crystal structure of Panus similis AA9A at room temperature | |
| 8E3J | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 4 | |
| 8E3P | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 5 | |
| 8E4C | P01872 | IgM BCR fab truncated form | |
| 8E4C | P11911 | IgM BCR fab truncated form | |
| 8E4C | P21578 | IgM BCR fab truncated form | |
| 8E4C | P15530 | IgM BCR fab truncated form | |
| 8E4I | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 6 | |
| 8E4K | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 7 | |
| 8E4Z | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 8 | |
| 8E56 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
| 8E56 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
| 8E56 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
| 8E57 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E57 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E57 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E58 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E58 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E58 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E59 | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E5A | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54284 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54289 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution |
